CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 18 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15,341 | +31208.2% | 10,436 | -58.3% | 0.00% | – |
| Q1 2023 | $49 | +6.5% | 25,040 | +22.9% | 0.00% | – |
| Q4 2022 | $46 | -99.8% | 20,376 | +88.1% | 0.00% | – |
| Q2 2022 | $22,000 | -45.0% | 10,835 | -23.7% | 0.00% | – |
| Q1 2022 | $40,000 | -98.8% | 14,207 | -97.7% | 0.00% | -100.0% |
| Q4 2015 | $3,230,000 | -9.3% | 614,092 | -0.5% | 0.01% | 0.0% |
| Q3 2015 | $3,560,000 | -19.2% | 617,065 | +0.2% | 0.01% | -12.5% |
| Q2 2015 | $4,404,000 | +7.8% | 615,959 | +0.4% | 0.01% | 0.0% |
| Q1 2015 | $4,085,000 | +6.2% | 613,430 | -4.7% | 0.01% | 0.0% |
| Q4 2014 | $3,848,000 | +35.4% | 643,433 | +11.9% | 0.01% | +14.3% |
| Q3 2014 | $2,841,000 | +24.9% | 575,000 | +13.8% | 0.01% | +16.7% |
| Q2 2014 | $2,274,000 | +77.8% | 505,304 | +77.8% | 0.01% | +50.0% |
| Q1 2014 | $1,279,000 | – | 284,144 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 739,917 | $5,135,000 | 2.89% |
| JW Asset Management, LLC | 263,881 | $1,830,000 | 0.38% |
| BARD ASSOCIATES INC | 442,825 | $3,075,000 | 0.29% |
| Ariel Investments | 1,393,125 | $9,668,000 | 0.11% |
| TFS CAPITAL LLC | 11,499 | $80,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 293,700 | $2,038,000 | 0.02% |
| DELTA ASSET MANAGEMENT LLC/TN | 12,000 | $83,000 | 0.01% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 10,945 | $76,000 | 0.01% |
| EAGLE GLOBAL ADVISORS LLC | 52,767 | $366,000 | 0.01% |
| Spark Investment Management LLC | 22,600 | $156,000 | 0.01% |